Lowering steroids for stable sarcoidosis
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This trial tests if people with stable sarcoidosis can safely lower their corticosteroid dose over time. It may help reduce side effects from long-term steroid use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with sarcoidosis by biopsy or your doctor's team
- You have been taking prednisolone 5-10 mg each day for more than 6 months
- Your sarcoidosis has been stable for at least 6 months (no flare-ups or dose increases)
- You may be on an additional second-line medication
- You are over 18 years old
- You do not have sarcoidosis affecting your heart or nervous system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two treatment durations—12 months versus 6 months—of the steroid prednisolone for people with lung sarcoidosis. It aims to see if a shorter course works just as well while reducing side effects.
This trial studies a treatment approach for people with active cardiac sarcoidosis, confirmed by specific heart rhythm/heart function problems and a PET scan. It may help by targeting the active inflammation driving heart conduction problems, rhythm events, or weak heart pumping.
This trial studies whether sirolimus (an immune-influencing medicine) can improve moderate-to-severe sarcoidosis affecting the face. It may help if you’ve tried standard sarcoidosis treatments before but they didn’t work well enough or stopped working.
This study looks at how the immune system works in people with sarcoidosis. It may help researchers find better ways to diagnose or treat the disease in the future.
This study measures blood levels of high-dose steroid medicines (prednisolone or related steroids) to understand how the body processes them in different real-life situations. It may help improve how steroids are dosed and monitored for people needing short-term or longer-term anti-inflammatory treatment.
This trial tests if a steroid combination medicine called Compound Betamethasone works well for people recently diagnosed with pulmonary sarcoidosis who haven't yet had treatment. The goal is to see if it can control the disease with fewer side effects than usual steroids.
Hear when a new Sarcoidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.